{"name":"CellSight Technologies, Inc.","slug":"cellsight-technologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOTlItdElSeV9EVzhheGZxRzAyblVrWXRRUDB1NEV1T1JXYXgwM1YyUk1qUjR0QUl6MEhwNXB5d1VuZWlSbFZvYVRZYUhPWTJGd19rS0s5UVE4TkNnR1hYekM0Z1RJM1dZVHltVnJxaHFkUU1MVl85UUY2V2tOdmdJbndYcUVCRnozT2JkQThQR1lvRmRHMmdwVF9FNWhtTHZmTmdGUjFOSlBvMEk1dXV5SzBwamhIdjFNenhROWUySmV1SlA5dGgwOE53V0lZd0J6SFdrVDB0Qk40YnVWWklQUnpIalNuLVFoRlZ2QkJ2elZHM1diUWxjWGVOaERMRjZWVklZc01uVFhLMm5jWjdZdk5pX0pCbHc?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Cancer Vaccines Market on Track for Major Expansion in the - GlobeNewswire","headline":"Cancer Vaccines Market on Track for Major Expansion in the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOdVlhOFhDYnpBRGh4WlhFWG93ZHdmak5FZDVRVC1qWER1YlFhbnQ5TThBM0Y5ZjJaaExucGI2LVNsSmRUMDQ3cVBHT211N1JHVXNBRklDUTR1VjdITWkxSTA5OXNTMkZ2S3hnVDBMNHJYamp2Ri1UcHhBRlBLUWNxLXFMeHRlXzFpOXpkRzF4NlZWYlBGS0xqaGlHSlMzMkRFcG1tRjd4aU5sOE5TUWJvdklNd0F5YmZIMU91Tng5X0F3UlJESVI1M0tDaUFid2c1MjlhMlFiTHNGaUViTkN3b01pM2J4cndGY0NueG9VTTl0bGtmWF9KcEpZOVlodHZQWE5FbW1aNDBzTTNZTVNWTWpWZjhVM00zcHZIUV9sTQ?oc=5","date":"2025-01-14","type":"trial","source":"PR Newswire","summary":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight - PR Newswire","headline":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Develop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPNjF6Q2RELUNROVAyUk9rcHpZRjNyNFVNd0VRckVmYllPSUxqZVVDQzZGblpUNElVbFlqcnhfOGV0MlRQcVRjRW1MeWVmRm9fODctUElhZXV1UzlUQ1hjN3NPdklHOUhfT3k4TGgwOUtBM2QtbDhPYVltRzh1N0J1M2xZSk1ETE92YXRzSGoyaUE3RVRhR1JPUmoxZXdGcGtMejNqcU1DODdLLVd1VldrMnBTZkZ1YUY5RWlpUkdDSTU2Y3VYWl9oWEVIZ0F4c0hPQ3pyUjN0b3M0V2dJREItams0TWtnM1JjdEsw?oc=5","date":"2024-12-16","type":"trial","source":"PR Newswire","summary":"CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-10-14","type":"regulatory","source":"PR Newswire UK","summary":"CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 Inhibitors in Early-stage Breast Cancer and the Emergence of Newer Players in Oth","headline":"CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 I","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxONUJNcFFlRkdKTHZjNGc5QnhhV3cwcXd3S09LUXZ4X2IwaHQxdzNJeThIVlNwdWJMMUhaaTB6ck9ob0s0emJVeS00eDRROFE0cUZ6M19fV0NZUWJBRllUcGV4RzR5TlJ4Qkw2YWVjRlduVU5laXUwOUhhbXpwNjBvRkVObG1vMko1N3FBWnJjbVNxSzVZX29DZk0yV3FueGp0cVA4eE9ZSk5fODYzNXJPZWpueWdZTWJ3bmpXMWU0RFc2XzVVZVJFekllUHRiX2JVZlYzcWp6YXdGaUYwN0VTc28tS0wzNU0?oc=5","date":"2024-09-30","type":"pipeline","source":"GlobeNewswire","summary":"KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight - GlobeNewswire","headline":"KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPT3ctSUhsLWpYcHlzTkxYT2hMMnp4S3VJNHZNVTIzSEtMSG8xeWtQSU9Rd3JLd011Vlg1NTZ6NjlfaUdNeHhZdE1JbjlFZEx6UnR2dF95dldVX1ZrcFdqVnZZTE9mcXJUM2xtSU5XbkdTN20tdk96cldFYmZFSXNjV2pSaUFlMXJYU3pHOVZWdHBrY2l4bi1ibTVFRms2ajE4emlwcTY1dDJic1hCYnNBZUtLVEl4OGVUUXdFUFhrWGd3Z2s2MWVoQ2JOeUdJU0NkLWc5enpVYmJtdW5KVlBnWUJISXVSdzUyT0tIb0dn?oc=5","date":"2024-08-30","type":"pipeline","source":"PR Newswire","summary":"ALK Inhibitors Market: A Comprehensive Overview of Current Trends and Future Projections | DelveInsight - PR Newswire","headline":"ALK Inhibitors Market: A Comprehensive Overview of Current Trends and Future Projections | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxObDVIWVNwRnJyeDlHUEptTzdZd0FtaEs5bzY2ZHZ6Qm9wRGlCelVzbjlFRVVubzBTQnBoVmJvR1k1TFkzMU9kSHowc2w5SGcxNmNmb1c5ZFp5ZVkxN1EyaXZrdktVNWZEWXNoLUVWQm9WRC1veDh5Vk5tWlJyT1FNUXpaYXp2b0RaSWxpMHl5Z0hua0hLM2VGb2dEMGxybEZNOEl5OW44emo3aGZoQzJ3eWpiYkNqcER3alpMazdFbWxOanNISWFMT2EtaFFwOG9NY00zWHo3dDlvUFM4WXUxNQ?oc=5","date":"2024-08-22","type":"pipeline","source":"PR Newswire","summary":"Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsight - PR Newswire","headline":"Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxOZjYwbklrS0dFNERFOXV2eW1rRXlZWkRkU1hRREZLZDUzeUZORExqTnpaRmJXYi1aclE2OVFLRVZRSVQ1SVRlX2hWaVZQUlhRcEsySFdVV0J0akFpQXJFQXY4ZExWaDNhbmI0b0FLUEExSGZEcXpmaE9ZUFhnd3p6QWRhcGNpVHhmZ0U3aGVWcDN2V0tia09jNVdQX3VQUDJncWpEd0NBcnRoVWxmWldFcUdyVG9jMW9lMXdHVXMyQ1laUzVKN0RncDlMUlhRSFJqOC0xYlpDM3k0YWNNQTdzTjl1SldDQ1V3ZGtrQlY5b1k5Ym9icWprbDdaYkkxU1BHUzR0V1g4VTNzRW05REdWamJsVnowMmJzaU9nMkMwU2pjSVNP?oc=5","date":"2024-07-11","type":"trial","source":"PR Newswire","summary":"Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutic","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-09-12","type":"pipeline","source":"University of Colorado Anschutz","summary":"CellSight Surpasses Benchmarks Toward Making Retinal Transplants a Reality - University of Colorado Anschutz","headline":"CellSight Surpasses Benchmarks Toward Making Retinal Transplants a Reality","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}